Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas S McCormick

Showing results (41-50 of 122) with videos related to

Pageof 13
Sort By:
Frontiers in Microbiology|March 15, 2018
Conceptual Perspectives: Bacterial Antimicrobial Peptide Induction as a Novel Strategy for Symbiosis with the Human HostSantosh K Ghosh, Zhimin Feng, Hisashi Fujioka, et al.
Pharmacological Research|September 18, 2025
Advances in Cutaneous Melanoma Therapy: The Emerging Role of CDK4/6 InhibitorsUriel Kim, Thomas S McCormick, Ankit Mangla, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2020
A Second-Generation Fungerp Analog, SCY-247, Shows Potent <i>In Vivo</i> Activity in a Murine Model of Hematogenously Disseminated Candida albicansSherman Chu, Lisa Long, Thomas S McCormick, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 2, 2018
Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discoveryQuanQiu Wang, Thomas S McCormick, Nicole L Ward, et al.
Frontiers in Cellular and Infection Microbiology|April 1, 2021
Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against <i>Candida glabrata</i>Ahmed Gamal, Sherman Chu, Thomas S McCormick, et al.
Nutrients|April 26, 2025
Small Intestinal Bacterial and Fungal Overgrowth: Health Implications and Management PerspectivesNatalie Soliman, Caroline Kruithoff, Erin Marie San Valentin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2011
Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppressionWendy A Goodman, Andrew B Young, Thomas S McCormick, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2021
<i>In Vitro</i> and <i>In Vivo</i> Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida aurisJanet Herrada, Ahmed Gamal, Lisa Long, et al.
Epigenetics|June 28, 2013
Comparison of epigenetic profiles of human oral epithelial cells from HIV-positive (on HAART) and HIV-negative subjectsSantosh K Ghosh, Thomas S McCormick, Betty L Eapen, et al.
BMC Microbiology|February 20, 2008
Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory FactorMingyue Wang, Pranab K Mukherjee, Jyotsna Chandra, et al.
Pageof 13

Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Frontiers in Microbiology|March 15, 2018
Conceptual Perspectives: Bacterial Antimicrobial Peptide Induction as a Novel Strategy for Symbiosis with the Human HostSantosh K Ghosh, Zhimin Feng, Hisashi Fujioka, et al.
Pharmacological Research|September 18, 2025
Advances in Cutaneous Melanoma Therapy: The Emerging Role of CDK4/6 InhibitorsUriel Kim, Thomas S McCormick, Ankit Mangla, et al.
Antimicrobial Agents and Chemotherapy|December 15, 2020
A Second-Generation Fungerp Analog, SCY-247, Shows Potent <i>In Vivo</i> Activity in a Murine Model of Hematogenously Disseminated Candida albicansSherman Chu, Lisa Long, Thomas S McCormick, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|June 2, 2018
Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discoveryQuanQiu Wang, Thomas S McCormick, Nicole L Ward, et al.
Frontiers in Cellular and Infection Microbiology|April 1, 2021
Ibrexafungerp, a Novel Oral Triterpenoid Antifungal in Development: Overview of Antifungal Activity Against <i>Candida glabrata</i>Ahmed Gamal, Sherman Chu, Thomas S McCormick, et al.
Nutrients|April 26, 2025
Small Intestinal Bacterial and Fungal Overgrowth: Health Implications and Management PerspectivesNatalie Soliman, Caroline Kruithoff, Erin Marie San Valentin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 11, 2011
Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppressionWendy A Goodman, Andrew B Young, Thomas S McCormick, et al.
Antimicrobial Agents and Chemotherapy|April 13, 2021
<i>In Vitro</i> and <i>In Vivo</i> Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida aurisJanet Herrada, Ahmed Gamal, Lisa Long, et al.
Epigenetics|June 28, 2013
Comparison of epigenetic profiles of human oral epithelial cells from HIV-positive (on HAART) and HIV-negative subjectsSantosh K Ghosh, Thomas S McCormick, Betty L Eapen, et al.
BMC Microbiology|February 20, 2008
Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory FactorMingyue Wang, Pranab K Mukherjee, Jyotsna Chandra, et al.
Pageof 13